FindTrial
Sign In

Studying clinical and hormonal characteristics of male patients with early androgenetic alopecia.

Assessing the prevalence,phenotypic characteristics, risk of insulin resistance and metabolic syndrome in male patients with early androgenetic alopecia and sex hormone imbalances.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/11/016269
Enrollment
100
Registered
2018-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E349- Endocrine disorder, unspecified

Interventions

None listed

Sponsors

Indian Association of Dermatologists Venereologists and Leprologists IADVL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of androgenetic alopecia aged under 30 years with a Norwood- Hamilton grade >=3

Exclusion criteria

Exclusion criteria: 1. Patients with severe systemic diseases. 2. Patients with alopecia other than androgenetic alopecia 3. Previous hormonal treatment or treatment with finasteride

Design outcomes

Primary

MeasureTime frame
â?¢ The study is aimed to assess the prevalence of insulin resistance and different parameters of metabolic syndrome in patients with a hormonal milieu resembling polycystic ovarian disease versus those who do not, namely; glycemic control; hyperinsulinemia; lipid profile; body mass index; blood pressure; waist circumference.Timepoint: Baseline—

Secondary

MeasureTime frame
â?¢ To assess the different phenotypic features which might act as pointers towards the expected subgroup of patients of early AGA with deranged sex hormone milieu.Timepoint: Baseline—

Countries

India

Contacts

Public ContactVinay Keshavamurthy

PGIMER Chandigarh

vinay.keshavmurthy@gmail.com8872993222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026